Expert Interview
Discussing the current supply chain and the potential impact that new tariffs could have on the biopharma industry.
Ticker(s): JNJ, LLY, NVO, NVS, AMGNInstitution: 2Seventy Bio
-
Global Supply Chain Manager; Cell & Gene Therapy at 2seventy bio.
-
Confident discussing supply chain impacts from tariffs on pharma, active ingredients (ai), or research products.
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
